Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-10 van der Velden Peter 10% owner Sale −139,450 $2.63 $367K 1,625,133
2023-01-10 van der Velden Peter 10% owner Sale −12,895 $2.63 $34K 150,275
2023-01-09 van der Velden Peter 10% owner Sale −132,845 $2.66 $354K 1,764,583
2023-01-09 van der Velden Peter 10% owner Sale −12,284 $2.66 $33K 163,170
2021-02-18 OAKES FRANK R. Director Sale −1,827 $7.25 $13K 0
2021-02-18 OAKES FRANK R. Director Sale −6,165 $7.25 $45K 0
2019-09-11 OAKES FRANK R. Director Sale −1,809 $5.72 $10K 6,165
2019-03-06 OAKES FRANK R. President & CEO Sale −4,000 $1.25 $5K 47,924
2018-10-12 MORSE DANIEL E. Former Director Sale −7,047 $1.31 $9K 20,741
2018-10-12 OAKES FRANK R. President & CEO Sale −3,000 $1.31 $4K 51,924
2018-03-29 MORSE DANIEL E. Director Sale −4,366 $0.81 $4K 0
2018-03-12 MORSE DANIEL E. Director Sale −3,500 $0.80 $3K 4,366
2018-03-09 MORSE DANIEL E. Director Sale −7,000 $0.81 $6K 7,866
2018-02-28 MORSE DANIEL E. Director Sale −7,000 $0.79 $6K 14,866
2018-02-26 MORSE DANIEL E. Director Sale −7,000 $0.79 $6K 21,866
2018-02-22 MORSE DANIEL E. Director Sale −7,800 $0.78 $6K 28,866

Page 1 of 1 · 16 trades